Nano Packaged Tamoxifen and Curcumin; Effective Formulation against Sensitive and Resistant MCF-7 Cells

Tamoxifen is routinely used for treatment of Estrogen-positive breast carcinoma. Approximately, 50% of patients with metastatic cancer will develop resistance to Tamoxifen. In this research, Tamoxifen was combined with the anti-cancer compound Curcumin. Diblocknanopolymer was used to package the new...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajigholami, Samira, Veisi Malekshahi, Ziba, Bodaghabadi, Narges, Najafi, Farhod, Shirzad, Hadi, Sadeghizadeh, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937073/
https://www.ncbi.nlm.nih.gov/pubmed/29755534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937073/
https://www.ncbi.nlm.nih.gov/pubmed/29755534

Ejemplares similares